Here are three main points:
1. The FDA is watching your social media! Companies cannot recommend any use of products considered “off label.”
2. Keep your social media in adherence with what the company claims in its 510k clearance. Mixed messages from sales reps or employees could create a problem.
3. There is a risk with the reward of advertising or promoting your organization on social media. Be careful not to accidentally post something against regulatory requirements.
Read more on ASCs…
Mark Cuban’s healthcare investment outlook: 5 key notes
6 strategies for securing patient health data
9 things to know about MedPAC’s 2015 ASC report
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.